Jonathan W. Friedberg, M.D., is Samuel Durand Professor of Medicine, and Director of the James P. Wilmot Cancer Institute at University of Rochester.
Dr. Friedberg received his medical degree from Harvard Medical School. His postgraduate training included an internship and residency at Massachusetts General Hospital. He also completed a medical oncology and hematology fellowship at Dana-Farber/Partners Cancer Care in Boston. Dr. Friedberg also has an M.M.Sc. degree from Harvard Medical School in clinical investigation.

His research interests focus on development of novel therapies for patients with lymphoma. He chairs the lymphoma committee of SWOG, a major network group of the NCTN. He has served as principal investigator on many local and national lymphoma treatment protocols for both Hodgkin lymphoma and non-Hodgkin's lymphoma. He is a member of the Scientific Advisory Board of the Lymphoma Research Foundation. He has served on several NCI study sections as well.

Dr. Friedberg also Editor-in Chief at Journal of Clinical Oncology. He has published over 200 manuscripts and serves as a mentor for several junior faculty members.